Alto Neuroscience ANRO Non-cash interest expense related to term loan
Non-cash interest expense related to term loan at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept alto:InterestExpenseNoncash.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's non-cash interest expense related to term loan.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's non-cash interest expense related to term loan?
- Alto Neuroscience (ANRO) reported non-cash interest expense related to term loan of $206K in Q1 2026.
- How has Alto Neuroscience's non-cash interest expense related to term loan changed year-over-year?
- Alto Neuroscience's non-cash interest expense related to term loan increased by 14.4% year-over-year, from $180K to $206K.
- What is the long-term trend for Alto Neuroscience's non-cash interest expense related to term loan?
- Over 2 years (2023 to 2025), Alto Neuroscience's non-cash interest expense related to term loan has grown at a 35.7% compound annual growth rate (CAGR), from $396K to $729K.
- What does non-cash interest expense related to term loan mean?
- Reflects the non-cash portion of interest expense, such as the amortization of debt discounts or premiums related to term loans. This adjustment is necessary to reconcile net income with cash flow from operations by removing accounting entries that do not involve cash outflows. Monitoring this helps investors distinguish between actual interest payments and non-cash accounting accruals.